跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
trypsinogen + chymotrypsinogen
首页
药物
trypsinogen + chymotrypsinogen
trypsinogen + chymotrypsinogen
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
Pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent
US 9636359 B2
申请人: KENYON JULIAN NORMAN
优先权: 2009
US
3 件公开
Cancer treatment
US 11376313 B2
申请人: PROPANC PTY LTD
优先权: 2016
CN
US
2 件公开
Method for extracting kallikreinogen by virtue of secondary affinity chromatography and pharmaceutical composition containing kallikreinogen
CN 104498462 A
申请人: QINGDAO KANGYUAN PHARMACEUTICAL CO LTD
优先权: 2014
CN
PROENZYME COMPOSITION
CN 108367054 A
申请人: PROPANC PTY LTD
优先权: 2015
CN
US 12419938 B2
申请人: PROPANC PTY LTD
优先权: 2016
US
Method for extracting prekallikrein by secondary affinity chromatography and pharmaceutical composition for improving stability of prekallikrein
CN 105385669 A
申请人: QINGDAO KANGYUAN PHARMACEUTICAL CO LTD
优先权: 2015
CN
COMPOSITION OF PROENZYMES FOR CANCER TREATMENT
CN 109152823 A
申请人: PROPANC PTY LTD
优先权: 2016
CN
Pharmaceutical composition containing a mixture of proenzymes and enzymes
US 11185587 B2
申请人: TRNKA FRANTISEK
优先权: 2019
US
药物
反馈
